title: Mitochondrial import and processing of mutant human ornithine transcarbamylase precursors in cultured cells.
abstract: We have investigated mitochondrial import and processing of the precursor for human ornithine transcarbamylase (OTC; carbamoylphosphate:L-ornithine carbamoyltransferase, EC 2.1.3.3) in HeLa cells stably transformed with cDNA sequences encoding OTC precursors carrying mutations in their leader peptides. The mutant precursors studied included two with amino acid substitutions in the 32-amino-acid leader peptide (glycine for arginine at position 23, designated gly23; glycines for arginines at positions 15, 23, and 26, designated gly15,23,26) and two with deletions (deletion of residues 8 to 22, designated d8-22; deletion of residues 17 to 32, designated N16). Specific immunoprecipitation with anti-OTC antiserum of extracts of L-[35S]methionine-labeled cells expressing these mutations yielded only precursor species; neither mature nor intermediate-size OTC subunits were observed. Fractionation of radiolabeled cells, however, revealed important differences among the various mutants: the gly23 precursor was associated with mitochondria and was not detected in the cytosol; the d8-22 and N16 precursors were found with both the mitochondrial fraction and the cytosol; only the gly15,23,26 precursor was detected exclusively in the cytosol. A large fraction of each of the mitochondrially associated OTC species was in a trypsin-protected compartment. In particular, the gly23 precursor behaved in trypsin protection and mitochondrial fractionation studies in a manner consistent with its translocation into the mitochondrial matrix. On the other hand, the lack of binding of the gly23 protein to a delta-N-phosphonoacetyl-L-ornithine affinity column, which specifically recognizes active OTC enzyme, indicated that, despite its intramitochondrial location, the mutant protein did not assemble into the normal, active trimer. Further, the gly23 mutant precursor was unstable within the mitochondria and was degraded with a t1/2 of less further than 4 h. Thus, we have shown that, in intact HeLa cells, cleavage of the OTC leader peptide is not required for translocation into mitochondria, but is required for assembly into active enzyme.
authors.affiliation: Department of Human Genetics, Yale University School of Medicine, New Haven, Connecticut 06510.
authors.forename: G
authors.initials: G
authors.lastname: Isaya
authors.forename: W A
authors.initials: WA
authors.lastname: Fenton
authors.forename: J P
authors.initials: JP
authors.lastname: Hendrick
authors.forename: K
authors.initials: K
authors.lastname: Furtak
authors.forename: F
authors.initials: F
authors.lastname: Kalousek
authors.forename: L E
authors.initials: LE
authors.lastname: Rosenberg
mesh_terms: D003600:Cytosol / Q000201:enzymology; D005822:Genetic Vectors; D006367:HeLa Cells / Q000201:enzymology; D006801:Humans; D007700:Kinetics; D008928:Mitochondria / Q000201:enzymology*; D009154:Mutation; D009954:Ornithine Carbamoyltransferase / Q000096:biosynthesis / Q000235:genetics*; D011499:Protein Processing, Post-Translational; D014162:Transfection
chemical_list: D009954:Ornithine Carbamoyltransferase